Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Prof. Dr. med. Dominik Hochli is a highly respected figure in orthopedic surgery and traumatology. He serves as the Head of the Department of Orthopedic Surgery and Traumatology at Inselspital, Bern University Hospital, and holds a professorship at the University of Bern. With extensive experience, his clinical work focuses on complex trauma care, joint reconstruction, and orthopedic oncology. Prof. Hochli is deeply involved in research, aiming to advance surgical techniques and improve patient outcomes. He is also committed to medical education, mentoring the next generation of orthopedic surgeons.
Dominik Hochli, MD's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Holds a professorship at the University of Bern, contributing significantly to academic research, curriculum development, and teaching in the field of orthopedics and trauma surgery.
Leads one of Switzerland's prominent orthopedic departments at Inselspital, Bern University Hospital, overseeing clinical excellence, research initiatives, and comprehensive patient care for a wide range of musculoskeletal conditions.
Recognized for his specialized skills in managing severe traumatic injuries, performing intricate joint reconstructions, and treating orthopedic oncology cases, often pioneering or adopting advanced surgical techniques.
Contributes extensively to orthopedic literature through numerous publications in peer-reviewed journals, focusing on areas such as trauma outcomes, innovative implant technologies, and surgical advancements in orthopedics.
Dedicated to training and mentoring medical students, residents, and fellows, fostering the development of future leaders in orthopedic surgery.
University of Bern - Year 1988
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Abivax is a clinical-stage biotechnology company focused on developing innovative therapies that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Their lead drug candidate, obefazimod (ABX464), is being evaluated for its potential to treat conditions such as ulcerative colitis, Crohn's disease, and rheumatoid arthritis. Obefazimod works by upregulating a specific microRNA (miR-124) which has demonstrated potent anti-inflammatory properties.
Get verified emails, phone numbers, and LinkedIn profile details
Discover contacts with similar roles, seniority, or companies
Uncover insights like skills, work history, social links, and more
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.